跳至主要内容
临床试验/NCT03799315
NCT03799315已完成不适用

Reducing Tobacco-Related Health Disparities Among Incarcerated Individuals in Hennepin County

Hennepin Healthcare Research Institute1 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2019年1月14日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
66
试验地点
1
主要终点
Bioverified 7-day point prevalence abstinence from smoking

研究概览

简要总结

Smoking rates remain above 60% for individuals involved in the criminal justice system and contribute to elevated mortality rates in this population. Addressing smoking disparities among justice-involved individuals is a critical public health issue in Minnesota, one of a few states with rising incarceration rates. People who are incarcerated represent the intersection of multiple high-priority populations (disproportionately African-American, Native American, low-income, homeless, on Medicaid, and suffering from mental illness and substance use disorders). This study examines the impact of a smoking cessation intervention for individuals discharged from jail to the community on smoking abstinence. Participants will be randomized to either 1) guideline-based, in-person smoking cessation counseling during incarceration, telephone counseling after incarceration, and nicotine replacement, or 2) enhanced treatment as usual. This study's findings will be used to develop a larger, multi-site study that is fully powered to measure longer-term health and smoking cessation outcomes.

详细描述

Outcome assessments will be conducted for both arms at 1 week, 3 weeks, and 12 weeks post discharge from jail. During these assessments, seven-day point prevalence abstinence will be bio-verified with exhaled carbon monoxide, and self-reported general health, physical health, mental health, and substance use measures will also be obtained. The analysis is fully powered (i.e., power > .8) to detect significant between group effects on the primary outcome (i.e., the longitudinal, between group effect on bio-verified seven-day point prevalence abstinence over the 3 weeks post discharge). All analyses will be conducted on the intent to treat sample and will utilize pre-specified logistic and linear regression models.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Use of ≥ 1 cigarette per day prior to incarceration
  • Expected release from the Hennepin Adult Detention Center to the community within 90 days
  • Age 18-64
  • English fluency
  • Lives within 20 minutes of Hennepin County Medical Center and has no plans to move away from area for 4 months
  • Willing to attempt quitting or reducing smoking at discharge
  • Has a telephone
  • Cleared for nicotine lozenge safety by jail health care provider and willing to use at discharge

排除标准

  • Active tuberculosis
  • Current mental health crisis (i.e., currently experiencing significant mania, psychosis, or suicidality)
  • Unable to ambulate independently
  • Acute medical condition that would impair participant's ability to follow-up for assessments
  • Expected discharge to a control institutional setting (e.g., locked state mental health facility or prison)
  • Active pregnancy
  • Heart attack within the last two weeks

研究组 & 干预措施

Jail-Based Use of Smoking Cessation Treatment (JUST)

Experimental

Participants will receive guidline-based smoking cessation counseling while in jail and phone-based smoking cessation counseling sessions and nicotine lozenges after release from jail.

干预措施: Nicotine Replacement Therapy (Drug)

Jail-Based Use of Smoking Cessation Treatment (JUST)

Experimental

Participants will receive guidline-based smoking cessation counseling while in jail and phone-based smoking cessation counseling sessions and nicotine lozenges after release from jail.

干预措施: Counseling (Behavioral)

结局指标

主要结局

Bioverified 7-day point prevalence abstinence from smoking

时间窗: Over 3 weeks

Bioverified 7-day point prevalence abstinence from smoking

次要结局

  • Time to Lapse(1 week, 3 weeks, 12 weeks)
  • Bio-verified 7-day point prevalence abstinence from smoking(Over 12 weeks)
  • Depressive symptoms(1 week, 3 weeks, 12 weeks)
  • Health-related quality of life(1 week, 3 weeks, 12 weeks)
  • Substance abuse(1 week, 3 weeks, 12 weeks)
  • Health care utilization(1 week, 3 weeks, 12 weeks)
  • Time to Relapse(3 weeks, 12 weeks)
  • Self-Reported Affect(1 week, 3 weeks, 12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Tyler Winkelman

Clinician-Investigator

Hennepin Healthcare Research Institute

研究点 (1)

Loading locations...

相似试验